AAML0523: A report from the Children's Oncology Group on the efficacy of clofarabine in combination with cytarabine in pediatric patients with recurrent acute myeloid leukemia

By Cooper Todd M.   Alonzo Todd A.   Gerbing Robert B.   Perentesis John P.   Whitlock James A.   Taub Jeffrey W.   Horton Terzah M.   Gamis Alan S.   Meshinchi Soheil   Loken Michael R.   Razzouk Bassem I.  

Cancer, Vol. 120, Iss. 16, 2014-08 ,pp. : 2482-2489

Blackwell Publishing

Access to resources Recommend Favorite

Comparative evaluation of local control strategies in localized Ewing sarcoma of bone: A report from the Children's Oncology Group

By DuBois Steven G.   Krailo Mark D.   Gebhardt Mark C.   Donaldson Sarah S.   Marcus Karen J.   Dormans John   Shamberger Robert C.   Sailer Scott   Nicholas Richard W.   Healey John H.   Tarbell Nancy J.   Randall R. Lor   Devidas Meenakshi   Meyer James S.   Granowetter Linda   Womer Richard B.   Bernstein Mark   Marina Neyssa   Grier Holcombe E.  

Cancer, Vol. 121, Iss. 3, 2015-02 ,pp. : 467-475

Blackwell Publishing

Access to resources Recommend Favorite

A randomized phase II evaluation of bryostatin-1 (NSC #339555) in persistent or recurrent squamous cell carcinoma of the cervix: A Gynecologic Oncology Group Study

By Armstrong Deborah K.   Blessing John A.   Rader Janet   Sorosky Joel I.  

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 453-457

Springer Publishing Company

Access to resources Recommend Favorite

A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3465-3471

Blackwell Publishing

Access to resources Recommend Favorite

Allergic reactions and antiasparaginase antibodies in children with high-risk acute lymphoblastic leukemia: A children's oncology group report

By  

Cancer, Vol. 121, Iss. 23, 2015-12 ,pp. : 4205-4211

Blackwell Publishing

Access to resources Recommend Favorite